Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.7.0 was added to the page, indicating an updated version of the study record. Several legacy study record update notes and related metadata were removed, reflecting an update to the page's history and organization.SummaryDifference18%

- Check36 days agoChange DetectedA new note indicates 2017 (U.S. NIH Grant/Contract) funding. The site revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov study page. This reflects a minor update to the page version rather than changes to the study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4, signaling a small frontend/metadata update to the study page. No study data or textual content appears to be altered.SummaryDifference0.0%

- Check93 days agoChange DetectedA new page revision (v3.6.3) was added to replace the previous revision (v3.6.2), indicating a minor update to the page's content or metadata.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0, indicating a software/template update. There are no apparent changes to the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.